Introduction
In December 2019, a novel pneumonia resulting from SARS-CoV2, named coronavirus disease 2019 (COVID-19), emerged in Wuhan [1] [2] . Due to the high viral contagiousness and transmission during the pre-symptomatic phase [3] [4] , progressively spread throughout China and has since become a global health issue [5] .
In China, Wuhan city, the capital of Hubei province, became the center of a COVID-19 outbreak [6] . In an effort to prevent a COVID-19 epidemic, Wuhan and its surrounding cities in Hubei province were locked down on January 23rd. However, a tremendous J o u r n a l P r e -p r o o f Journal Pre-proof number of patients who were still in their incubation period traveled across China before the lockdown date due to Chinese New Year, resulting in the widespread transmission of COVID-19. Hunan province is adjacent to Hubei province. By March 20th, 2020, a total of 1018 confirmed cases had been reported in Hunan, most of which showed familial clustering.
The average incubation period for COVID-19 is reported to be 2 to 14 days, and most patients show symptoms within 11.5 days [7 -8] . To stop the spread of the disease, public health officials in Hunan placed those who may have been from Wuhan and exposed to COVID-19 under quarantine for 14 days. However, the incubation period may be longer in some patients. Here, we report on the last COVID-19 familial cluster in Hunan province, which was hospitalized on February 28. The disease was not confirmed until 40 days after the index patient had returned from Wuhan.
Patients and Methods

Case source
On February 28th, a new COVID-19 case was confirmed in the Fourth People's Hospital of Yiyang. In following the patient's epidemiological history, it emerged that this was a familial cluster. Afterward, we further collected the clinical data of the patient's family members, including epidemiological history, laboratory examinations, lung CTs, pathogen results, treatment course, and recovery. All the clinical data were collected from the 4th People's Hospital of Yiyang, and all the epidemiological histories of the patients were gathered from the patients themselves; these data were further confirmed by the local Centers for Disease Control.
All the information used in this article was approved by the patients.
J o u r n a l P r e -p r o o f according to the manufacturer's instructions [9] . The IgG/IgM of Chlamydophila pneumoniae and Mycoplasma pneumoniae were also tested for using the SeroMP kit 
Results
Five cases were detected in our research, all of whom were from the same family. 
Discussion
The ongoing outbreak of COVID-19, starting in December 2019, has quickly become a sweeping and unprecedented global challenge. Because COVID-19 can spread from person to person [10] [11] , a major challenge in controlling the disease is recognizing and quarantining potential infectious sources as soon as possible [12] .
As Li reported, the median incubation period is 4-5.2 days and the 95th percentile of the distribution is 12.5 days [13] . Unfortunately, COVID-19 patients can be infective before the disease onset and maintain infective ability during the convalescent phase [3, 4, and 14] . According to Cao's report [15] , the shortest observed duration of viral shedding was 8 days, whereas the longest was 37 days. and the shedding duration of SARS-CoV2 might be extremely long in this case. The index patient did not develop atypical symptoms (including a mild cough and a runny nose) until 28 days after she had returned from Wuhan. Remarkably, Case 1 was immunocompromised due to her long-term use of oral prednisone, which might explain why she did not develop typical symptoms at first and why she had a longer duration of viral shedding.
In summary, it is important to recognize potential patients who might have no or only mild symptoms. Therefore, we highly recommend that all people with an exposure history be strictly quarantined, and for immunocompromised people with long-term use of glucocorticoids, this time should not be limited to 14 days. J o u r n a l P r e -p r o o f
